Unlock Premium for Just $9.99/Month – Special Launch Offer, Limited Time Only
Get Premium
ATAI ATAI Life Sciences NV
- Stocks
- Healthcare
- NASDAQ: ATAI
Price (delayed)
$1.65
Market cap
$330.56M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$0.91
Enterprise value
$308.94M
Highlights
ATAI's EPS is up by 2.2% since the previous quarter
ATAI's quick ratio is down by 49% year-on-year but it is up by 31% since the previous quarter
The equity has declined by 32% year-on-year but it has increased by 31% since the previous quarter
The debt is up by 28% year-on-year and by 8% since the previous quarter
Key stats
What are the main financial stats of ATAI
Market
Valuations
Earnings
Shares outstanding
200.34M
Market cap
$330.56M
Enterprise value
$308.94M
Price to earnings (P/E)
N/A
Price to book (P/B)
2.15
Price to sales (P/S)
156.12
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
165.83
Revenue
$1.86M
Gross profit
$1.86M
Operating income
-$98.97M
Net income
-$148.99M
EBIT
-$145.85M
EBITDA
-$144.77M
Free cash flow
-$77.98M
Per share
Balance sheet
Liquidity
EPS
-$0.91
EPS diluted
-$0.91
Free cash flow per share
-$0.44
Book value per share
$0.77
Revenue per share
$0.01
TBVPS
$1.09
Total assets
$195.78M
Total liabilities
$43.51M
Debt
$26.67M
Equity
$152.05M
Working capital
$87.48M
Debt to equity
0.18
Current ratio
4.07
Quick ratio
3.8
Net debt/EBITDA
0.15
Margins
Efficiency
Dividend
EBITDA margin
-7,770.7%
Gross margin
100%
Net margin
-7,997.2%
Operating margin
-5,312.2%
Return on assets
-77.6%
Return on equity
-102.4%
Return on invested capital
-89.7%
Return on capital employed
-87.2%
Return on sales
-7,828.6%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
ATAI stock price
How has the ATAI Life Sciences stock price performed over time
Intraday
1.23%
1 week
18.71%
1 month
16.2%
1 year
-11.29%
YTD
24.06%
QTD
21.32%
Financial performance
How have ATAI Life Sciences's revenue and profit performed over time
Revenue
$1.86M
Gross profit
$1.86M
Operating income
-$98.97M
Net income
-$148.99M
Gross margin
100%
Net margin
-7,997.2%
ATAI Life Sciences's operating margin has soared by 87% YoY and by 84% from the previous quarter
The net margin has surged by 83% since the previous quarter and by 34% year-on-year
ATAI Life Sciences's operating income has increased by 15% YoY and by 3.6% from the previous quarter
Price vs fundamentals
How does ATAI's price correlate with its fundamentals
Growth
What is ATAI Life Sciences's growth rate over time
Valuation
What is ATAI Life Sciences stock price valuation
P/E
N/A
P/B
2.15
P/S
156.12
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
165.83
ATAI's EPS is up by 2.2% since the previous quarter
The P/B is 34% more than the last 4 quarters average of 1.6 and 2.4% more than the 5-year quarterly average of 2.1
The equity has declined by 32% year-on-year but it has increased by 31% since the previous quarter
ATAI's P/S is 79% below its 5-year quarterly average of 758.3 and 68% below its last 4 quarters average of 486.9
Efficiency
How efficient is ATAI Life Sciences business performance
ATAI's ROS has soared by 84% since the previous quarter and by 28% year-on-year
The company's return on invested capital fell by 17% QoQ
The company's return on equity fell by 12% QoQ
ATAI's ROA is down by 9% since the previous quarter
Dividends
What is ATAI's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for ATAI.
Financial health
How did ATAI Life Sciences financials performed over time
ATAI's quick ratio is down by 49% year-on-year but it is up by 31% since the previous quarter
The current ratio has contracted by 48% YoY but it has grown by 27% from the previous quarter
The debt is 82% smaller than the equity
The company's debt to equity has surged by 100% YoY but it fell by 14% QoQ
The equity has declined by 32% year-on-year but it has increased by 31% since the previous quarter
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.